Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

TRXSCanary Staked TRX ETF

CBOE · CIK 0002064768
Filer category—
Entity typeoperating
SIC6221 Commodity Contracts Brokers & Dealers
FY end1231
XBRL facts47

Identity from submissions API

NameCanary Staked TRX ETF
CIK0002064768
TickersTRXS
ExchangesCBOE
Entity typeoperating
Category—
SIC6221 Commodity Contracts Brokers & Dealers
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(310) 795-8899
Website—
Investor website—
Owner org09 Crypto Assets
Flags—
Description—
Insider transactions (issuer)0
Insider transactions (owner)0

Former names

  • None listed.
Business address
8 CADILLAC DRIVE
SUITE 300
BRENTWOOD
TN
37027
TN
Mailing address
8 CADILLAC DRIVE
SUITE 300
BRENTWOOD
TN
37027
TN

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

11 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 10-Q FORM 10-Q 0001999371-26-025341 001-43472 261554122 34 2225010 1 1
2026-09-09 CERT CBOE BZX CERTIFICATION 0001417835-26-000293 001-43472 261366668 34 226881
2026-09-08 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002908 333-286628 261366514 33 1721
2026-09-08 8-A12B/A AMENDMENT TO FORM 8-A12B 0001999371-26-020132 001-43472 261365566 34 25686
2026-09-08 424B3 PROSPECTUS FILED PURSUANT TO RULE 424B3 0001999371-26-020129 333-286628 261365556 33 1042800
2026-09-08 8-A12B FORM FOR THE REGISTRATION / LISTING OF A CLASS OF SECURITIES 0001999371-26-020097 001-43472 261364588 34 25719
2026-08-19 S-1/A AMENDMENT TO FORM S-1 0001999371-26-018236 333-286628 261296454 33 1987090
2026-07-24 S-1/A AMENDMENT TO FORM S-1 0001999371-26-015859 333-286628 261202319 33 2656833
2026-06-24 S-1/A AMENDMENT TO FORM S-1 0001999371-26-013365 333-286628 261115312 33 1032604
2026-05-15 S-1/A AMENDMENT TO FORM S-1 0001999371-26-010857 333-286628 26985746 33 981754
2025-04-18 S-1 GENERAL FORM OF REGISTRATION STATEMENT 0001999371-25-004423 333-286628 25850349 33 1020022

Latest XBRL company facts

One latest value per concept from companyfacts (47 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 2.03M 2026-11-09 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 50.75M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap Assets Assets USD 50.70M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap AssetsNet Net Assets USD 50.67M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap CommonStockNoParValue Common Stock, No Par Value USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 2.03M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 2.03M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap CryptoAssetCost CryptoAssetCost USD 50.82M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap CryptoAssetCustomerReceipt CryptoAssetCustomerReceipt USD 50.25M 2026-09-09 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap CryptoAssetFairValue CryptoAssetFairValue USD 50.70M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap CryptoAssetFairValueRestricted CryptoAssetFairValueRestricted USD 45.55M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap CryptoAssetNumberOfRestrictedUnits CryptoAssetNumberOfRestrictedUnits Unit 134.82M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap CryptoAssetNumberOfUnits CryptoAssetNumberOfUnits Unit 150.06M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap CryptoAssetPurchase CryptoAssetPurchase USD 502,879 2026-09-09 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD -114,859 2026-09-09 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap GrossInvestmentIncomeOperating Gross Investment Income, Operating USD 76,103 2026-09-09 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement USD 45,517 2026-09-09 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap InvestmentCompanyExpenseRatioIncludingIncentiveFee Investment Company, Expense Ratio Including Incentive Fee pure 0.015 2026-09-09 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap InvestmentCompanyGainLossOnInvestmentPerShare Investment Company, Gain (Loss) on Investment, Per Share USD/shares -0.07 2026-09-09 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap InvestmentCompanyIncreaseDecreaseFromShareTransaction InvestmentCompanyIncreaseDecreaseFromShareTransaction USD 50.75M 2026-09-09 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap InvestmentCompanyInvestmentIncomeLossPerShare Investment Company, Investment Income (Loss), Per Share USD/shares 0.03 2026-09-09 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap InvestmentCompanyInvestmentIncomeLossRatio Investment Company, Investment Income (Loss) Ratio pure 0.01 2026-09-09 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap InvestmentCompanyMarketValuePerShare InvestmentCompanyMarketValuePerShare USD/shares 24.99 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease Investment Company, Net Asset Value Per Share, Period Increase (Decrease) USD/shares -0.04 2026-09-09 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap InvestmentCompanyTotalReturn Investment Company, Total Return pure -0.002 2026-09-09 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap InvestmentCompanyTotalReturnMarketValue InvestmentCompanyTotalReturnMarketValue pure -0 2026-09-09 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap InvestmentIncomeInvestmentExpense Investment Income, Investment Expense USD 45,517 2026-09-09 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap InvestmentOwnedAtCost Investment Owned, at Cost USD 50.82M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap InvestmentOwnedAtFairValue Investment Owned, at Fair Value USD 50.70M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap InvestmentOwnedPercentOfNetAssets Investment Owned, Percent of Net Assets pure 1 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap Liabilities Liabilities USD 33,508 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap ManagementFeePayable Management Fee Payable USD 33,508 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap NetAssetValuePerShare Net Asset Value Per Share USD/shares 24.96 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -84,273 2026-09-09 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap NetInvestmentIncome Net Investment Income USD 30,586 2026-09-09 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap NonInvestmentAssetsLessNonInvestmentLiabilities Non Investment Assets Less Non Investment Liabilities USD -33,508 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets Non Investment Assets Less Non Investment Liabilities, Percent of Net Assets pure -0.001 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 250,000 2026-09-07 2026-09-08 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -84,273 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 25 2026-09-08 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap SponsorFees Sponsor Fees USD 33,508 2026-09-09 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 50.67M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap StockholdersEquityPeriodIncreaseDecrease Stockholders' Equity, Period Increase (Decrease) USD 50.67M 2026-09-09 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 2.03M 2026-09-09 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap StockIssuedDuringPeriodSharesPeriodIncreaseDecrease Stock Issued During Period, Shares, Period Increase (Decrease) shares 2.03M 2026-09-09 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 50.75M 2026-09-09 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -114,859 2026-09-09 2026-09-30 2026 Q3 10-Q 2026-11-13 0001999371-26-025341

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →